| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. | Chief Medical Officer | Stock Options | 150,000 | 18 Jan 2024 | Direct | ||
| Longeveron Inc. | Director | Stock Option (Right to buy) | 12,000 | 21 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CVKD | Cadrenal Therapeutics, Inc. | 18 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 19 Jan 2024, 19:38 |
| LGVN | Longeveron Inc. | 21 Dec 2023 | 1 | $0 | 4 | Director | 26 Dec 2023, 18:00 |
| CVKD | Cadrenal Therapeutics, Inc. | 19 Jan 2023 | 0 | $0 | 3/A | Chief Medical Officer | 31 Mar 2023, 06:16 |
| LGVN | Longeveron Inc. | 21 Dec 2022 | 1 | $0 | 4 | Director | 22 Dec 2022, 17:00 |